This action may contribute to improved metabolic health and other associated benefits
(PubMed) Zhang S, Hunter DJ, Forman MR, et al
While much of the available data comes from preclinical studies, interest in its biological activity continues to grow due to its interaction with multiple physiological pathways
In April 2026, the FDA removed BPC-157 from its Category 2 list (substances with safety concerns that were previously restricted from compounding)
Oral BPC-157 is ideal for gastrointestinal conditions because the peptide is stable in gastric juice and acts locally on the digestive tract
Certain medical conditions and medications increase B12 requirements: Long-term use of metformin (diabetes medication) or proton pump inhibitors (PPIs for acid reflux) can impair B12 absorption [13] [14] Gastrointestinal conditions such as Crohn's disease, coeliac disease, or previous gastric surgery Autoimmune conditions beyond pernicious anaemia may affect B12 metabolism When to contact your GP : If you are taking B12 supplements or receiving injections but continue to experience symptoms, request a review